Cargando…
Treatment strategies for the right heart in pulmonary hypertension
The function of the right ventricle (RV) determines the prognosis of patients with pulmonary hypertension. While much progress has been made in the treatment of pulmonary hypertension, therapies for the RV are less well established. In this review of treatment strategies for the RV, first we focus o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852547/ https://www.ncbi.nlm.nih.gov/pubmed/28957540 http://dx.doi.org/10.1093/cvr/cvx148 |
_version_ | 1783306590699388928 |
---|---|
author | Westerhof, Berend E. Saouti, Nabil van der Laarse, Willem J. Westerhof, Nico Vonk Noordegraaf, Anton |
author_facet | Westerhof, Berend E. Saouti, Nabil van der Laarse, Willem J. Westerhof, Nico Vonk Noordegraaf, Anton |
author_sort | Westerhof, Berend E. |
collection | PubMed |
description | The function of the right ventricle (RV) determines the prognosis of patients with pulmonary hypertension. While much progress has been made in the treatment of pulmonary hypertension, therapies for the RV are less well established. In this review of treatment strategies for the RV, first we focus on ways to reduce wall stress since this is the main determinant of changes to the ventricle. Secondly, we discuss treatment strategies targeting the detrimental consequences of increased RV wall stress. To reduce wall stress, afterload reduction is the essential. Additionally, preload to the ventricle can be reduced by diuretics, by atrial septostomy, and potentially by mechanical ventricular support. Secondary to ventricular wall stress, left-to-right asynchrony, altered myocardial energy metabolism, and neurohumoral activation will occur. These may be targeted by optimising RV contraction with pacing, by iron supplement, by angiogenesis and improving mitochondrial function, and by neurohumoral modulation, respectively. We conclude that several treatment strategies for the right heart are available; however, evidence is still limited and further research is needed before clinical application can be recommended. |
format | Online Article Text |
id | pubmed-5852547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58525472018-03-23 Treatment strategies for the right heart in pulmonary hypertension Westerhof, Berend E. Saouti, Nabil van der Laarse, Willem J. Westerhof, Nico Vonk Noordegraaf, Anton Cardiovasc Res Invited Spotlight Reviews The function of the right ventricle (RV) determines the prognosis of patients with pulmonary hypertension. While much progress has been made in the treatment of pulmonary hypertension, therapies for the RV are less well established. In this review of treatment strategies for the RV, first we focus on ways to reduce wall stress since this is the main determinant of changes to the ventricle. Secondly, we discuss treatment strategies targeting the detrimental consequences of increased RV wall stress. To reduce wall stress, afterload reduction is the essential. Additionally, preload to the ventricle can be reduced by diuretics, by atrial septostomy, and potentially by mechanical ventricular support. Secondary to ventricular wall stress, left-to-right asynchrony, altered myocardial energy metabolism, and neurohumoral activation will occur. These may be targeted by optimising RV contraction with pacing, by iron supplement, by angiogenesis and improving mitochondrial function, and by neurohumoral modulation, respectively. We conclude that several treatment strategies for the right heart are available; however, evidence is still limited and further research is needed before clinical application can be recommended. Oxford University Press 2017-10 2017-09-05 /pmc/articles/PMC5852547/ /pubmed/28957540 http://dx.doi.org/10.1093/cvr/cvx148 Text en © The Author 2017. Published on behalf of the European Society of Cardiology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Invited Spotlight Reviews Westerhof, Berend E. Saouti, Nabil van der Laarse, Willem J. Westerhof, Nico Vonk Noordegraaf, Anton Treatment strategies for the right heart in pulmonary hypertension |
title | Treatment strategies for the right heart in pulmonary hypertension |
title_full | Treatment strategies for the right heart in pulmonary hypertension |
title_fullStr | Treatment strategies for the right heart in pulmonary hypertension |
title_full_unstemmed | Treatment strategies for the right heart in pulmonary hypertension |
title_short | Treatment strategies for the right heart in pulmonary hypertension |
title_sort | treatment strategies for the right heart in pulmonary hypertension |
topic | Invited Spotlight Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852547/ https://www.ncbi.nlm.nih.gov/pubmed/28957540 http://dx.doi.org/10.1093/cvr/cvx148 |
work_keys_str_mv | AT westerhofberende treatmentstrategiesfortherightheartinpulmonaryhypertension AT saoutinabil treatmentstrategiesfortherightheartinpulmonaryhypertension AT vanderlaarsewillemj treatmentstrategiesfortherightheartinpulmonaryhypertension AT westerhofnico treatmentstrategiesfortherightheartinpulmonaryhypertension AT vonknoordegraafanton treatmentstrategiesfortherightheartinpulmonaryhypertension |